Oct 23rd, 2015

Valeant Under Scrutiny, Veritas Searches for Truth

Veritas Investment Research CEO Anthony Scilipoti discusses Valeant Pharmaceuticals woes. Bloomberg's Drew Armstrong also reports on "Bloomberg Markets." (Source: Bloomberg)